Literature DB >> 21938739

Oct-3/4 promotes migration and invasion of glioblastoma cells.

Kana Kobayashi1, Hisaaki Takahashi, Akihiro Inoue, Hironobu Harada, Shinichi Toshimori, Yukako Kobayashi, Katsuhiro Goto, Kana Sugimoto, Hajime Yano, Takanori Ohnishi, Junya Tanaka.   

Abstract

As a result of increased glioblastoma migration and invasion into normal brain parenchyma, treatment of local tumor recurrence following initial treatment in glioblastoma patients remains challenging. Recent studies have demonstrated increased Oct-3/4 expression, a self-renewal regulator in stem cells, in glioblastomas. However, little is known regarding the influence of Oct-3/4 in glioblastoma cell invasiveness. The present study established Oct-3/4-overexpressing glioblastoma cells, which were prepared from human glioblastoma patients, to assess migration, invasion, and mRNA expression profiles of integrins and matrix metalloproteinases (MMPs). Compared with control cells, Oct-3/4 expressing-glioblastoma cells exhibited increased migration and invasion in wound healing and Matrigel invasion assays. Oct-3/4 overexpression resulted in upregulated FAK and c-Src expression, which mediate integrin signals. Vinculin accumulated along the leading edges of Oct-3/4 expressing-glioblastoma cells and associated with membrane ruffles during cell migration. Oct-3/4 expressing-cells exhibited increased MMP-13 mRNA expression and MMP-13 knockdown by shRNA suppressed cell invasion into Matrigel and organotypic brain slices. These results suggested that Oct-3/4 enhanced degradation of surrounding extracellular matrix by increasing MMP-13 expression and altering integrin signaling. Therefore, Oct-3/4 might contribute to tumor promoting activity in glioblastomas.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21938739     DOI: 10.1002/jcb.23374

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  15 in total

1.  Nanog increases focal adhesion kinase (FAK) promoter activity and expression and directly binds to FAK protein to be phosphorylated.

Authors:  Baotran Ho; Gretchen Olson; Sheila Figel; Irwin Gelman; William G Cance; Vita M Golubovskaya
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

2.  Constitutive activation of myosin-dependent contractility sensitizes glioma tumor-initiating cells to mechanical inputs and reduces tissue invasion.

Authors:  Sophie Y Wong; Theresa A Ulrich; Loic P Deleyrolle; Joanna L MacKay; Jung-Ming G Lin; Regina T Martuscello; Musa A Jundi; Brent A Reynolds; Sanjay Kumar
Journal:  Cancer Res       Date:  2015-01-29       Impact factor: 12.701

Review 3.  FAK and Nanog cross talk with p53 in cancer stem cells.

Authors:  Vita M Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2013-05       Impact factor: 2.505

4.  Transcriptomics of cortical gray matter thickness decline during normal aging.

Authors:  P Kochunov; J Charlesworth; A Winkler; L E Hong; T E Nichols; J E Curran; E Sprooten; N Jahanshad; P M Thompson; M P Johnson; J W Kent; B A Landman; B Mitchell; S A Cole; T D Dyer; E K Moses; H H H Goring; L Almasy; R Duggirala; R L Olvera; D C Glahn; J Blangero
Journal:  Neuroimage       Date:  2013-05-24       Impact factor: 6.556

5.  MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation.

Authors:  Bing-Lin Zhu; Yan Long; Wei Luo; Zhen Yan; Yu-Jie Lai; Li-Ge Zhao; Wei-Hui Zhou; Yan-Jiang Wang; Lin-Lin Shen; Lu Liu; Xiao-Juan Deng; Xue-Feng Wang; Fei Sun; Guo-Jun Chen
Journal:  Brain       Date:  2019-01-01       Impact factor: 13.501

Review 6.  Systematic review of protein biomarkers of invasive behavior in glioblastoma.

Authors:  Eli T Sayegh; Gurvinder Kaur; Orin Bloch; Andrew T Parsa
Journal:  Mol Neurobiol       Date:  2013-11-24       Impact factor: 5.590

Review 7.  Targeting FAK in human cancer: from finding to first clinical trials.

Authors:  Vita M Golubovskaya
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

8.  POU5F1 enhances the invasiveness of cancer stem-like cells in lung adenocarcinoma by upregulation of MMP-2 expression.

Authors:  Yan-hong Xin; Bai-shi-jiao Bian; Xiao-jun Yang; Wei Cui; Hong-juan Cui; You-hong Cui; Xia Zhang; Chuan Xu; Xiu-wu Bian
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

9.  TLX activates MMP-2, promotes self-renewal of tumor spheres in neuroblastoma and correlates with poor patient survival.

Authors:  P L Chavali; R K R Saini; Q Zhai; D Vizlin-Hodzic; S Venkatabalasubramanian; A Hayashi; E Johansson; Z-j Zeng; S Mohlin; S Påhlman; L Hansford; D R Kaplan; K Funa
Journal:  Cell Death Dis       Date:  2014-10-30       Impact factor: 8.469

10.  A Truncated form of CD200 (CD200S) Expressed on Glioma Cells Prolonged Survival in a Rat Glioma Model by Induction of a Dendritic Cell-Like Phenotype in Tumor-Associated Macrophages.

Authors:  Kana Kobayashi; Hajime Yano; Akihiro Umakoshi; Shirabe Matsumoto; Ayano Mise; Yu Funahashi; Yoshitomo Ueno; Yoshiaki Kamei; Yasutsugu Takada; Yoshiaki Kumon; Takanori Ohnishi; Junya Tanaka
Journal:  Neoplasia       Date:  2016-04       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.